SCHEMBL5503211

SCHEMBL5503211

CN1CCN(CCNCC(=O)Nc2cccc(Nc3ncc(-c4ccsc4)cn3)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
CTSL P07711 1/20 0.44
CTSC P53634 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
MET P08581 1/20 0.42
ALK Q9UM73 1/20 0.42
ABL1 P00519 1/20 0.41
PDGFRB P09619 1/20 0.41
BCR P11274 1/20 0.41
SRC P12931 1/20 0.41
PDGFRA P16234 1/20 0.41
SYK P43405 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EGFR P00533 4/20 0.40
MYLK Q15746 1/20 0.39
KDR P35968 2/20 0.39
BRD4 O60885 3/20 0.38
KIT P10721 1/20 0.38
FLT1 P17948 1/20 0.38
FYN P06241 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5494608 0.92 CTSC (0.40) ALDH1A1CTSLCTSCL3MBTL1MET
SCHEMBL5526330 0.91 TSHR (0.43) ALDH1A1CTSLCTSCMETALK
SCHEMBL5499970 0.88 LIMK1 (0.48) ALDH1A1CTSLCTSCABL1PDGFRB
SCHEMBL5499013 0.85 CTSC (0.44) ALDH1A1CTSLCTSCABL1PDGFRB
SCHEMBL5499148 0.82 MEN1 (0.43) ALDH1A1SMN1; SMN2EGFR
SCHEMBL5534432 0.81 CTSC (0.52) ALDH1A1CTSLCTSCMETALK
SCHEMBL5503212 0.81 POLB (0.57) ALDH1A1CTSLCTSCMETALK
SCHEMBL5499927 0.81 LIMK1 (0.41) CTSLCTSCABL1BCREGFR
SCHEMBL5500661 0.81 ABL1 (0.64) ALDH1A1ABL1PDGFRBBCRSRC
SCHEMBL14342368 0.81 EGFR (0.54) ALDH1A1CTSLCTSCABL1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US claimed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP claimed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO claimed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 ALDH1A1 3195/4885CTSL 4370/4885CTSC 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.